Bio-Techne Corporation
TECHDividend PayerAutomated dividend-safety read-out from payout, leverage, yield, profitability and track record. See the Financials tab for the full per-statement Financial Investigation. Educational only — not investment advice.
At a glance
Bio-Techne Corporation (TECH) operates in the Biotechnology industry and is based in the United States. It pays a quarterly dividend of $0.32 a year, a yield of 0.44% at the current price of $72.62. Over the last five years the dividend has grown by an average of 0.0% a year. It paid out 28% of its earnings as dividends, leaving most of its profit in the business. 13 analysts cover it; their average 12-month price target of $70.50 is 2.9% below the current price.
Written automatically from the figures on this page, as of Oct 23, 2026. Facts only, not a recommendation.
About Bio-Techne Corporation
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies.
Business description sourced from Yahoo Finance / company filings. Not affiliated with SimplyWallStreet.
Key Metrics
Valuation
Profitability
Financial Health
Data provided by Yahoo Finance via yfinance. Updated daily. Not investment advice.